Mario Seres
Overview
Explore the profile of Mario Seres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurekova S, Pavlikova L, Seres M, Bohacova V, Spaldova J, Breier A, et al.
Cancer Cell Int
. 2025 Feb;
25(1):35.
PMID: 39920654
In previous research, we revealed that murine leukemia cells L1210 with induced expression of P-glycoprotein (P-gp, a membrane drug transporter, product of the Abcb1 gene) are better able to withstand...
2.
Seres M, Spacayova K, Sulova Z, Spaldova J, Breier A, Pavlikova L
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858030
The epidermal growth factor receptor (EGFR) regulates gene expression through two primary mechanisms: as a growth factor in the nucleus, where it translocates upon binding its ligand, or via its...
3.
Pavlikova L, Seres M, Breier A, Sulova Z
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205839
Cancer chemotherapy may induce a multidrug resistance (MDR) phenotype. The development of MDR is based on various molecular causes, of which the following are very common: induction of ABC transporter...
4.
Paulikova H, Cisarikova A, Bacova Z, Janovec L, Imrich J, Seres M, et al.
Neoplasma
. 2021 Sep;
68(6):1169-1180.
PMID: 34585585
Efforts to overcome multidrug resistance in cancer have led to the development of several novel strategies including photodynamic therapy (PDT). PDT is based on the use of photosensitizers (PSs) photoactivation,...
5.
Kyca T, Pavlikova L, Bohacova V, Misak A, Poturnayova A, Breier A, et al.
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34071136
In this paper, we compared the effects of bortezomib on L1210 (S) cells with its effects on P-glycoprotein (P-gp)-positive variant S cells, which expressed P-gp either after selection with vincristine...
6.
Cagala M, Pavlikova L, Seres M, Kadlecikova K, Breier A, Sulova Z
Molecules
. 2020 Jun;
25(11).
PMID: 32481618
Four new variants of L1210 cells resistant to endoplasmic reticulum (ER) stressors, tunicamycin (S), thapsigargin (S), bortezomib (S), and MG-132 (S), were developed via an 18-month periodic cultivation in culture...
7.
Seres M, Pavlikova L, Bohacova V, Kyca T, Borovska I, Lakatos B, et al.
Cells
. 2020 Apr;
9(4).
PMID: 32268491
P-glycoprotein (P-gp, ABCB1 member of the ABC (ATP-binding cassette) transporter family) localized in leukemia cell plasma membranes is known to reduce cell sensitivity to a large but well-defined group of...
8.
Kubickova J, Elefantova K, Pavlikova L, Cagala M, Seres M, Safar P, et al.
Molecules
. 2019 Jun;
24(11).
PMID: 31195716
We describe the screening of a set of cryptopleurine derivatives, namely thienoquinolizidine derivatives and (epi-)benzo analogs with bioactive phenanthroquinolizidine alkaloids that induce cytotoxic effects in the mouse lymphocytic leukemia cell...
9.
Bohacova V, Seres M, Pavlikova L, Kontar S, Cagala M, Bobal P, et al.
Molecules
. 2018 May;
23(5).
PMID: 29723984
The acceleration of drug efflux activity realized by plasma membrane transporters in neoplastic cells, particularly by P-glycoprotein (P-gp, ABCB1 member of the ABC transporter family), represents a frequently observed molecular...
10.
Hano M, Tomasova L, Seres M, Pavlikova L, Breier A, Sulova Z
Molecules
. 2018 Feb;
23(2).
PMID: 29415493
Multidrug resistance (MDR) is a phenotype of cancer cells with reduced sensitivity to a wide range of unrelated drugs. P-glycoprotein (P-gp)-a drug efflux pump (ABCB1 member of the ABC transporter...